Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

The pandemic accelerated economic disparity, revealing a disturbing acceptance of mass death. Did we learn nothing?

Her facility had faced allegations about its central role in the emergence of SARS-CoV-2. READ ALSO: Is another pandemic just around the corner? Chinese scientists discover a new bat coronavirus ...

CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

ALSO READ: What is HKU5-CoV-2 ... receptors—the same receptors used by SARS-CoV-2 for infection. According to the study, which was published in the peer-reviewed journal Cell, the virus can ...

New COVID Variant: In 2019, the world saw the emergence of the deadliest virus outbreak SARS-CoV-2, which caused COVID-19. This deadly virus evaded the human immune system, targeting the ...

Also Read: The unsettled debate about Covid origins Researchers stated that like SARS-CoV-2, the new virus also has a feature known as the furin cleavage site that helps it to enter cells via the ...

Although several vaccines and drugs are available against SARS-CoV-2, the search for effective therapeutic agents for COVID-19 and future zoonotic coronaviruses continues. The RNA-dependent RNA ...